Sort
48,018 grants matching “immunotherapy”
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,651,519Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2014 · CA
Immunological Strategies to Modulate SIV Rebound Following ART Interruption
$1,650,523Michael R Betts · University Of Pennsylvania · P01 · FY2017 · AI
Clinical Trials of Patients with AIDS-Related Malignancies
$1,650,515Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Pathogenesis and countermeasures of poxviruses and hemorrhagic fever viruses
$1,649,808Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (AC
$1,648,842Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2015 · AI
Methamphetamine Abuse Research Center
$1,648,585Aaron J. Janowsky · Oregon Health & Science University · P50 · FY2015 · DA
Immune repertoire remodeling following B cell-targeted CAR T cells for induction of renal allograft tolerance in non-human primates
$1,648,086Ali Naji · University Of Pennsylvania · R01 · FY2025 · AI
Deciphering CTCF code in mammalian host and viral epigenomes
$1,647,549Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
AIDS CLINICAL TRIALS UNIT
$1,647,267University Of Pennsylvania · U01 · FY2003 · AI
DNA Sequencing and FACS Core Facilities
$1,646,795Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Understanding and Altering the Virologic Setpoint
$1,645,592Aaron Diamond Aids Research Center · U01 · FY2004 · AI
MECHANISMS PROGRAMMING PROTECTIVE IMMUNITY FROM RhCMV-SIV VACCINE AND IL-15 ACTIONS
$1,645,537Michael J Gale · University Of Washington · P01 · FY2023 · AI
UCLA SPORE in Prostate Cancer
$1,643,637Robert E Reiter · University Of California Los Angeles · P50 · FY2022 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$1,643,516University Of Washington · U01 · FY2003 · AI
Mechanisms Underlying Clearance of Persistent Infections and Tumors
$1,642,842Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Clinical and Mechanistic Investigations of Salivary Gland Dysfunction
$1,642,409Blake Warner · National Institute Of Dental & Craniofacial Research · ZIA · FY2024 · DE
Innate Immune Antivirals for Biodefense
$1,642,398Michael J Gale · University Of Washington · R01 · FY2014 · AI
Novel Approaches to Stem Cell Transplantation
$1,642,204Duke University · P01 · FY2005 · CA
AIDS CLINICAL TRIALS UNIT
$1,640,820University Of California Los Angeles · U01 · FY2001 · AI
Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers
$1,639,796Robert J. Canter · University Of California At Davis · U01 · FY2017 · CA
ADULT AIDS CLINICAL TRIALS UNIT (ACTU)
$1,639,776University Of Southern California · U01 · FY2003 · AI
The Johns Hopkins Translational Science Team for the ET-CTN
$1,639,503Michael A. Carducci · Johns Hopkins University · UM1 · FY2019 · CA
Comprehensive dissection of the CLL genome and phenome to improve patient outcomes
$1,639,141Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Molecular Pathogenesis of Neoplasia
$1,639,115John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Epigenetic and immunologic aspects of neuroendocrine cancers
$1,638,645Nitin Roper · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA